You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene Antibodies (MET)
On are 555 Met Proto-Oncogene (MET) Antibodies from 31 different suppliers available. Additionally we are shipping MET Kits (62) and MET Proteins (50) and many more products for this protein. A total of 693 MET products are currently listed.
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all antibodies Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

Most Popular Reactivities for anti-MET (MET) Antibodies

Select your species and application

anti-Human MET Antibodies:

anti-Mouse (Murine) MET Antibodies:

anti-Rat (Rattus) MET Antibodies:

All available anti-MET Antibodies

Go to our pre-filtered search.

Top referenced anti-MET Antibodies

  1. Human Monoclonal MET Primary Antibody for FACS, IHC (p) - ABIN1688523 : Zagouri, Bago-Horvath, Rössler, Brandstetter, Bartsch, Papadimitriou, Dimitrakakis, Tsigginou, Papaspyrou, Giannos, Dimopoulos, Filipits: High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. in British journal of cancer 2013 (PubMed)
    Show all 36 references for ABIN1688523

  2. Human Polyclonal MET Primary Antibody for EIA, IHC (p) - ABIN358164 : Wong, Roskelley, Pelech, Miller, Leung, Auersperg: Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. in Experimental cell research 2004 (PubMed)
    Show all 5 references for ABIN358164

  3. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN358165 : Higuchi, Orita, Katsuya, Yamasaki, Akiyama, Li, Yamamoto, Saito, Nakamura: MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met. in Molecular and cellular biology 2004 (PubMed)
    Show all 5 references for ABIN358165

  4. Human Polyclonal MET Primary Antibody for WB - ABIN197460 : Gherardi, Youles, Miguel, Blundell, Iamele, Gough, Bandyopadhyay, Hartmann, Butler: Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. in Proceedings of the National Academy of Sciences of the United States of America 2003 (PubMed)
    Show all 4 references for ABIN197460

  5. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN401383 : Fan, Ma, Gao, Yuan, Meng, Goldberg, Rosen: The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. in Molecular and cellular biology 2001 (PubMed)
    Show all 3 references for ABIN401383

  6. Human Polyclonal MET Primary Antibody for IF (p), IHC (p) - ABIN671661 : Gao, Bing, Li, Yang, Li, Chen: Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma. in Medical oncology (Northwood, London, England) 2013 (PubMed)
    Show all 2 references for ABIN671661

  7. Human Polyclonal MET Primary Antibody for IF, ELISA - ABIN1533596 : Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003 (PubMed)
    Show all 2 references for ABIN1533596

  8. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN389595 : Guo, Prins, Dang, Kuga, Iwanami, Soto, Lin, Huang, Akhavan, Hock, Zhu, Kofman, Bensinger, Yong, Vinters, Horvath, Watson, Kuhn, Robins, Mehta, Wen, DeAngelis, Prados, Mellinghoff, Cloughesy, Mischel: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. in Science signaling 2009 (PubMed)
    Show all 2 references for ABIN389595

  9. Human Polyclonal MET Primary Antibody for DB - ABIN389596 : Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function. in The Journal of biological chemistry 2011 (PubMed)

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. Data indicate that oncogene (show RAB1A Antibodies) c-Met was a putative target of microRNA miR (show MLXIP Antibodies)-139-5p.

  2. Study identified the G-quadruplex structure in MET promoter and showed its importance in binding to the Sp1 (show PSG1 Antibodies) activator promoting tumor growth.

  3. Data show that silencing of fibroblast growth factor receptors FGFR1 or FGFR2 overcomes resistance to the proto-oncogene proteins c-met (MET) inhibitor.

  4. Data show that inhibition of ATP binding cassette subfamily B member 1 (ABCB1) might be a novel therapeutic strategy for non-small cell lung cancer (NSCLC) patients with acquired resistance to proto-oncogene proteins c-met (MET) inhibitors.

  5. Results indicate that proto-oncogene protein c-MET (MET) expression was significantly associated with MET amplification.

  6. Report the application of advanced quantitative fluorescence microscopy techniques to study changes in the oligomerization state of the RTK Met in response to stimulation by its endogenous ligand hepatocyte growth factor (show HGF Antibodies).

  7. Results show that overexpression of c-MET and its phosphorylation with up-regulation of VEGFR1 (show FLT1 Antibodies) are associated with chemo-resistance phenotype of colon cancer.

  8. High c-Met expression is associated with small cell hypercalcemic ovarian carcinoma.

  9. The findings suggest that the oncogenic activity of hepsin (show HPN Antibodies) arises not only from elevated expression level but also from depletion of HAI-1 (show SPINT1 Antibodies), events which together trigger gain-of-function activity impacting HGF (show HGF Antibodies)/MET signalling and epithelial cohesion

  10. analysis of ARID1A (show ARID1A Antibodies), CDH1 (show CDH1 Antibodies), cMET and PIK3CA (show PIK3CA Antibodies) expression and target-related microRNA expression in gastric cancer

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF Antibodies) expression patterns and levels, but impairs HGF (show HGF Antibodies) bioavailability

  2. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  3. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  4. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR Antibodies) that may play a role in fertilization.

  5. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA Antibodies))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF Antibodies).

  6. HGF and c-met inhibition by means of a novel monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and in mouse xenografts.

  7. facilitates T cell recruitment to the heart via CCR5 (show CCR5 Antibodies) receptor by inducing autocrine CCR5 (show CCR5 Antibodies) ligand release

  8. C-Met pathway is suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.

  9. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.

  10. HGFR activation is regulated by integrin beta-1 (show ITGB1 Antibodies). Decreased Itgb1 (show ITGB1 Antibodies) leads to decreased HGFR activation.

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • AI838057 antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • Hgfr antibody
  • Par4 antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for anti-MET (MET) Antibodies
Did you look for something else?